Strategies used to enhance checkpoint inhibition in Hodgkin lymphoma
Paul Jan Bröckelmann • 17 Oct 2022
Predicting treatment outcomes in patients with r/r cHL with ctDNA and PET
Carmelo Carlo-Stella • 2 Dec 2021
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.